HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Nobuhara Selected Research

Gefitinib (Iressa)

3/2005Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Nobuhara Research Topics

Disease

1Neoplasms (Cancer)
03/2005
1Anaplastic Thyroid Carcinoma
03/2005
1Dementia (Dementias)
10/2004
1Mitochondrial Myopathies (Mitochondrial Myopathy)
10/2004
1Alexander Disease (Alexander's Disease)
10/2004
1Atrophy
10/2004
1Breast Neoplasms (Breast Cancer)
12/2001
1Atherosclerosis
05/2001

Drug/Important Bio-Agent (IBA)

1Epidermal Growth Factor (EGF)IBA
03/2005
1ErbB Receptors (EGF Receptor)IBA
03/2005
1Tyrosine Kinase InhibitorsIBA
03/2005
1Gefitinib (Iressa)FDA Link
03/2005
1Mitochondrial DNA (mtDNA)IBA
10/2004
1Glial Fibrillary Acidic ProteinIBA
10/2004
1LuciferasesIBA
12/2001
1Polystyrenes (Polystyrene)IBA
12/2001
1Estrogen ReceptorsIBA
12/2001
1Styrene (Styrol)IBA
12/2001
1NTE 122IBA
05/2001
1Sterol O-AcyltransferaseIBA
05/2001
1CholesterolIBA
05/2001

Therapy/Procedure

1Therapeutics
03/2005
1Molecular Targeted Therapy
03/2005